tiprankstipranks
Trending News
More News >
Renishaw PLC (GB:RSW)
LSE:RSW

Renishaw (RSW) AI Stock Analysis

Compare
29 Followers

Top Page

GB

Renishaw

(LSE:RSW)

Rating:74Outperform
Price Target:
2,932.00p
▲(3.06%Upside)
Renishaw exhibits a strong financial foundation and strategic corporate actions that bode well for future growth. Technical indicators suggest moderate performance, while valuation and dividend yield provide a balanced investment opportunity. The strategic restructuring and leadership confidence bolster the company's market position.
Positive Factors
Market Demand
There is a more favorable order intake environment expected, driven by semiconductor manufacturing and consumer electronics markets.
Portfolio Management
Encouragement is drawn from signs of value-creating portfolio management.
Trade Relations
There is likely to be a healthy relief rally supported by the growing news of a US/UK trade deal.
Negative Factors
Financial Performance
The 2Q slowdown for Renishaw has resulted in a decline in revenue and adjusted profit before tax, indicating financial challenges.
Investor Confidence
Guidance suggests significant downgrades to consensus estimates, which could affect investor confidence.
Profitability
The shares have outperformed the sector recently, but the anticipated inflection in profitability may not materialize, putting pressure on the stock.

Renishaw (RSW) vs. iShares MSCI United Kingdom ETF (EWC)

Renishaw Business Overview & Revenue Model

Company DescriptionRenishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services metrology and healthcare products worldwide. The company offers co-ordinate measuring machine (CMM) products, machine tool probe and software, performance measurement systems, gauging systems, fixtures, and styli for touch probe systems; interferometric laser, magnetic, and optical encoders; additive manufacturing systems; plastics and metal vacuum casting machines; and mapping sensors. It also provides healthcare products, such as dental scanners, neurosurgical robots and accessories, neurosurgical planning software, drug delivery systems, Raman microscopes, craniomaxillofacial customized implants, analysers, and hybrid Raman systems. In addition, the company offers asset financing and travel agency services. It serves the aerospace, agriculture, automotive, construction, consumer electronics, healthcare, power generation, resource exploration, energy, heavy, medical, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is headquartered in Wotton-under-Edge, the United Kingdom.
How the Company Makes MoneyRenishaw makes money through the sale of its precision measurement equipment and healthcare products. Its primary revenue streams include the metrology and healthcare sectors, where it provides advanced technology solutions to a wide range of industries, including aerospace, automotive, and healthcare. The company also generates income through service and maintenance contracts for its equipment, as well as from its research and development activities, which lead to innovative product offerings. Strategic partnerships and collaborations with industry leaders further contribute to Renishaw's earnings by expanding its market reach and enhancing its product portfolio.

Renishaw Financial Statement Overview

Summary
Renishaw demonstrates stable revenue growth and robust operational efficiency with a strong balance sheet characterized by minimal leverage. However, slight pressure on profitability is evident from decreased net profit margins.
Income Statement
75
Positive
Renishaw's income statement shows stable revenue growth with a 1.41% increase in the latest year. Gross profit margin remains robust at 46.8%, although it has slightly decreased from previous years. The net profit margin has also decreased to 14.0%, indicating some pressure on profitability. However, the company maintains a solid EBIT margin of 15.7% and an EBITDA margin of 22.6%, demonstrating operational efficiency.
Balance Sheet
80
Positive
The balance sheet is strong with a very low debt-to-equity ratio of 0.02, indicating minimal leverage and financial risk. The equity ratio is high at 85.9%, reflecting a strong equity base. Return on equity stands at 10.7%, which is decent, though it has declined from previous levels, suggesting reduced profitability on equity.
Cash Flow
70
Positive
Renishaw exhibits a positive free cash flow growth of 686.9% year-over-year, signaling significant improvement in cash generation. The operating cash flow to net income ratio is 1.28, which shows strong cash flow relative to net income. The free cash flow to net income ratio is 0.51, indicating moderate free cash flow relative to net earnings.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
702.21M691.30M681.67M673.70M567.44M509.48M
Gross Profit
381.06M326.94M434.00M438.78M369.64M325.16M
EBIT
112.68M108.67M126.26M167.92M117.83M57.36M
EBITDA
140.56M156.07M166.39M174.02M172.36M48.37M
Net Income Common Stockholders
97.64M96.89M116.10M120.35M111.46M288.00K
Balance SheetCash, Cash Equivalents and Short-Term Investments
233.16M217.84M206.39M253.16M225.59M130.95M
Total Assets
1.04B1.05B1.04B992.77M856.88M766.46M
Total Debt
17.49M18.54M13.33M16.26M20.01M24.71M
Net Debt
-72.67M-103.75M-66.87M-124.95M-84.08M-94.47M
Total Liabilities
148.11M148.56M146.88M177.60M153.55M219.59M
Stockholders Equity
896.29M903.40M897.24M815.75M703.91M547.44M
Cash FlowFree Cash Flow
100.63M49.30M6.27M82.58M111.81M46.06M
Operating Cash Flow
148.78M124.08M90.87M122.24M135.53M105.46M
Investing Cash Flow
-91.29M-31.50M-76.90M-28.01M-134.43M-12.28M
Financing Cash Flow
-48.85M-52.70M-60.74M-55.30M-17.84M-37.62M

Renishaw Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2845.00
Price Trends
50DMA
2487.60
Positive
100DMA
2753.15
Positive
200DMA
3026.17
Negative
Market Momentum
MACD
64.15
Negative
RSI
63.84
Neutral
STOCH
68.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RSW, the sentiment is Positive. The current price of 2845 is above the 20-day moving average (MA) of 2656.25, above the 50-day MA of 2487.60, and below the 200-day MA of 3026.17, indicating a neutral trend. The MACD of 64.15 indicates Negative momentum. The RSI at 63.84 is Neutral, neither overbought nor oversold. The STOCH value of 68.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:RSW.

Renishaw Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£105.39M19.778.61%0.89%-11.80%-32.11%
GBSXS
76
Outperform
£3.31B14.3417.33%3.39%-11.09%65.87%
GBRSW
74
Outperform
£1.98B20.3011.07%0.62%4.71%0.43%
GBGHH
71
Outperform
£150.59M29.084.79%2.91%1.74%359.50%
71
Outperform
£644.79M26.318.07%1.16%-5.56%-27.87%
GBJDG
70
Neutral
£525.16M50.4012.29%0.95%-1.84%9.56%
62
Neutral
$11.96B10.09-7.50%3.10%7.33%-8.11%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:RSW
Renishaw
2,845.00
-951.59
-25.06%
GB:GHH
Gooch & Housego
590.00
88.12
17.56%
GB:JDG
Judges Scientific
8,000.00
-1,776.54
-18.17%
GB:SOLI
Solid State
186.00
-111.11
-37.40%
GB:SXS
Spectris
3,310.00
391.20
13.40%
GB:DSCV
discoverIE Group plc
667.00
-8.09
-1.20%

Renishaw Corporate Events

Product-Related AnnouncementsBusiness Operations and Strategy
Renishaw Unveils Strategic Plans at Capital Markets Day
Positive
Jun 17, 2025

Renishaw hosted a Capital Markets Day to outline strategic progress and financial goals, including new product releases and changes to segmental reporting. The company aims to drive revenue growth through innovation, improve margins, and enhance shareholder returns with a new cost reduction program targeting £20 million in savings. The event highlighted significant investments in manufacturing capacity and introduced new business segments to better align with market demands.

The most recent analyst rating on (GB:RSW) stock is a Buy with a £4180.00 price target. To see the full list of analyst forecasts on Renishaw stock, see the GB:RSW Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Renishaw Reports Steady Q3 Growth Amid Strategic Restructuring
Positive
May 8, 2025

Renishaw plc reported steady progress in its third quarter, with revenue reaching £180.7 million, marking a 5% increase year-on-year. The company experienced growth in machine tool probes and position encoders, while also announcing the closure of its loss-making drug delivery segment in the Neurological business to enhance profitability. Despite challenges such as tariffs and increased labor costs, Renishaw maintains a strong balance sheet and continues to focus on productivity and strategic investments to support future growth.

Other
Renishaw CEO Acquires Shares, Signaling Confidence in Company
Positive
Apr 14, 2025

Renishaw plc announced a transaction involving its Chief Executive, William Ernest Lee, who acquired 1,788 ordinary shares at a price of £22.37 each on the London Stock Exchange. This acquisition reflects a significant investment by the company’s leadership, potentially indicating confidence in Renishaw’s future performance and market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.